Author(s): Hardcastle IR, Golding BT, Griffin RJ
Keywords: cell cycle cancer chemotherapy experimental therapeutics SELECTIVE INHIBITOR GROWTH-INHIBITION STRUCTURAL BASIS PURINE ANALOGS POTENT CDK2 CDC2 ROSCOVITINE CONSTITUENT ACTIVATION
|
Professor Bernard Golding
|
|